Clinical Trials in New York

Showing 14761-14780 of 22,668 trials

The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes

NCT00327236

The investigators believe that T cells, cells that are a part of the immune system, are what are causing the neurological problems while also attacking tumor cells. This protocol studies the clinical status of patients with paraneoplastic neurological disorder (PND) as well as their blood to understand the relationship between their neurological disease, their cancer, and their immune system.

Paraneoplastic Syndromes

Rockefeller University109 participantsStarted Jan 1995

New York, New York, United States

COMPLETEDPhase 2< 1 mile

Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer

NCT03081481

The purpose of this study is to determine a safe, effective, and tolerable dose of PRX302 for the treatment of low to intermediate risk prostate cancer.

Prostate Cancer

Sophiris Bio Corp38 participantsStarted Jun 2017

Ocala, Florida, United States • Baltimore, Maryland, United States • New York, New York, United States +5 more locations

UNKNOWNNA< 1 mile

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

NCT00772317

For the treatment of locally recurrent prostate cancer following failed external beam radiation therapy (EBRT)

Recurrent Prostate Cancer

SonaCare Medical117 participantsStarted Jul 2008

Los Angeles, California, United States • Los Angeles, California, United States • Washington D.C., District of Columbia, United States +13 more locations

The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes

Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

Find Trials by Condition in New York

Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis (LN)

Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence

Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers

Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator

Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users

EnMotion, Embryo's Natural Motion

16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis

Resilience-Based Program for Support Partners of Persons With Multiple Sclerosis

Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure

Selonsertib in Adults With Pulmonary Arterial Hypertension

Seeing-Moving-Playing: Early Rehabilitation Utilizing Visual and Vestibular Technology Following Traumatic Brain Injury

Frequency of Screening and SBT Technique Trial